Recently published results from a clinical trial show DNA screening may help doctors more effectively treat mesothelioma patients using chemotherapy. […]
|
||||
Recently published results from a clinical trial show DNA screening may help doctors more effectively treat mesothelioma patients using chemotherapy. […] Recently published results from a clinical trial show DNA screening may help doctors more effectively treat mesothelioma patients using chemotherapy. […] The immunotherapy drug avelumab showed promising results in a recent phase I clinical trial for malignant mesothelioma, raising hopes as a future second-line therapy. The clinical trial included 53 patients with pleural or peritoneal mesothelioma. It was part of the JAVELIN development program for avelumab, a series of clinical studies testing the drug on about… The post Immunotherapy Trial for Mesothelioma Shows Early Promise appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families. […] The company’s president hopes they’ll be filing for FDA approval by the end of the trial. […] |